pH-responsive nano carriers for doxorubicin delivery. 2015

Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
Graduate Department of Polymer Science and Technology, Middle East Technical University, Ankara, Turkey.

OBJECTIVE The aim of this study was to design stimuli-responsive nanocarriers for anti-cancer drug delivery. For this purpose, doxorubicin (DOX)-loaded, polysebacic anhydride (PSA) based nanocapsules (NC) were combined with pH-sensitive poly (L-histidine) (PLH). METHODS PSA nano-carriers were first loaded with DOX and were coated with poly L-histidine to introduce pH sensitivity. The PLH-coated NCs were then covered with polyethylene glycol (PEG) to reduce macrophage uptake. The drug release profile from this system was examined in two different buffer solutions prepared as acidic (pH5) and physiological (pH 7.4) media. The physical and chemical properties of the nanocapsules were characterized by Fourier transform infrared spectroscopy (FTIR), dynamic light scattering (DLS), ultraviolet and visible absorption spectroscopy (UV-VIS), and scanning electron microscopy (SEM). In vitro studies of the prepared nanocapsules were conducted in MDA-MB-231 breast cancer cells. RESULTS The results obtained by SEM and DLS revealed that nanocapsules have spherical morphology with an average size of 230 nm. Prepared pH sensitive nanocapsules exhibited pH-dependent drug release profile and promising intracellular release of drug. PEGylation of nanoparticles significantly prevented macrophage uptake compared to non-PEGylated particles.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003652 Decanoic Acids 10-carbon saturated monocarboxylic acids. Capric Acids,Acids, Capric,Acids, Decanoic
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006639 Histidine An essential amino acid that is required for the production of HISTAMINE. Histidine, L-isomer,L-Histidine,Histidine, L isomer,L-isomer Histidine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
August 2019, Molecules (Basel, Switzerland),
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
December 2011, Journal of drug targeting,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
April 2021, Nanotechnology,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
September 2015, Journal of controlled release : official journal of the Controlled Release Society,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
April 2022, Pharmaceutics,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
August 2010, Biomaterials,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
June 2021, Molecules (Basel, Switzerland),
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
August 2018, Molecular pharmaceutics,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
January 2013, International journal of pharmaceutics,
Shahla Bagherifam, and Frode Miltzow Skjeldal, and Gareth Griffiths, and Gunhild M Mælandsmo, and Olav Engebråten, and Bo Nyström, and Vasif Hasirci, and Nesrin Hasirci
January 2016, Acta biomaterialia,
Copied contents to your clipboard!